Lau K W, Gao W, Ding Z P, Kwok V
Singapore Heart Center, Singapore.
Coron Artery Dis. 1996 Apr;7(4):327-33. doi: 10.1097/00019501-199604000-00010.
Emergency stent implantation for the treatment of failed balloon angioplasty has been limited by a 3-33% incidence of early stent thrombosis and a paucity of information on restenosis. Accordingly, the objective of this study is to determine both the acute and midterm results following single bailout stenting for threatened closure after failed balloon angioplasty.
Single stent placement with either a Gianturco-Roubin or Palmaz-Schatz stent for the treatment of threatened closure complicating conventional single-vessel balloon angioplasty of de novo native coronary lesions was carried out in 16 and 24 patients, respectively.
Successful stent implantation was achieved in 39 patients (97.5%), reducing the diameter stenosis from 90 +/- 7% before 6 +/- 8% after the procedure. No early stent closure, myocardial infarction, or need for emergency coronary bypass surgery was observed. Furthermore, except for one death due to massive intracranial hemorrhage 1 1/2 weeks after a successful stent implantation, there was no mortality directly related to the procedure. Repeat angiographic study performed at a mean of 5 +/- 3 months after stenting in 30 (86 %) eligible patients revealed in-stent restenosis (> 50% diameter stenosis) in six patients (20%). Five had successful repeat balloon angioplasty. Restenosis rate was significantly higher in patients with diabetes mellitus (83 versus 21% in nondiabetics, P = 0.0047), who had small (< 3 mm diameter) stent (reflecting small vessel diameters) implanted (40 versus 10% for > or = 3 mm stents, P = 0.0528) and those who had received stents to rectify vessel recoil (60 versus 12% for dissection, P = 0.0264). During a follow-up period of 12 +/- 8 months, clinical benefits were maintained in most patients, with none requiring bypass surgery, and no myocardial infarction or death encountered.
Our study suggests that single bailout stenting for threatened closure in selected patients is associated with a favorable short and mid-term outcome, with minimal risk of early stent closure and a low restenosis rate. Restenosis rate, however, remains high in diabetic patients, stent placement for vessel recoil indication and those receiving < 3 mm diameter stents.
急诊支架植入术用于治疗球囊血管成形术失败的情况,一直受到早期支架血栓形成发生率为3% - 33%以及再狭窄信息匮乏的限制。因此,本研究的目的是确定在球囊血管成形术失败后进行单次补救性支架置入以防止血管闭塞的急性和中期结果。
分别对16例和24例患者进行了单支架置入,使用Gianturco - Roubin或Palmaz - Schatz支架治疗因原发性冠状动脉病变的常规单支血管球囊血管成形术并发的血管闭塞风险。
39例患者(97.5%)成功植入支架,使直径狭窄率从术前的90±7%降至术后的6±8%。未观察到早期支架闭塞、心肌梗死或急诊冠状动脉搭桥手术的需求。此外,除了1例在成功植入支架1.5周后因大量颅内出血死亡外,没有与手术直接相关的死亡病例。对30例(86%)符合条件的患者在支架置入后平均5±3个月进行的重复血管造影研究显示,6例患者(20%)出现支架内再狭窄(直径狭窄>50%)。5例患者成功进行了重复球囊血管成形术。糖尿病患者的再狭窄率显著更高(糖尿病患者为83%,非糖尿病患者为21%,P = 0.0047),植入小直径(<3 mm)支架(反映血管直径较小)的患者再狭窄率也更高(直径≥3 mm支架为40%,<3 mm支架为10%,P = 0.0528),以及接受支架以纠正血管回缩的患者(血管夹层为60%,非血管夹层为12%,P = 0.0264)。在12±8个月的随访期内,大多数患者保持了临床获益,无人需要进行搭桥手术,也未发生心肌梗死或死亡。
我们的研究表明,在选定患者中进行单次补救性支架置入以防止血管闭塞与良好的短期和中期结果相关,早期支架闭塞风险最小,再狭窄率低。然而,糖尿病患者、因血管回缩指征置入支架的患者以及接受直径<3 mm支架的患者再狭窄率仍然很高。